B16-F10 melanoma cells contribute to the new formation of blood vessels in the chick embryo chorioallantoic membrane through vasculogenic mimicry

Clinical and Experimental Medicine

Volumn 13, Issue 2, 2013, Pages 143-147

  Ribatti, Domenico ^a   Nico, Beatrice ^a   Cimpean, Anca Maria ^b   Raica, Marius ^b   Crivellato, Enrico ^c   Ruggieri, Simona ^a   Vacca, Angelo ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c UNIVERSITY OF UDINE   (Italy)

Author keywords

Angiogenesis; Chorioallantoic membrane; Melanoma; Vasculogenic mimicry

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; MELAN A; PROTEIN S 100;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CHICK EMBRYO; CHORIOALLANTOIS; EPITHELIUM; MELANOMA CELL; MESENCHYME; NONHUMAN; PRIORITY JOURNAL;

ALLANTOIS; ANIMALS; CELL MOVEMENT; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; ENDOTHELIUM; MART-1 ANTIGEN; MELANOMA, EXPERIMENTAL; MESODERM; NEOVASCULARIZATION, PATHOLOGIC; S100 PROTEINS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84877772628     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-012-0183-8     Document Type: Article

References (26)

1. Ribatti D (2010) The chick embryo chorioallantoic membrane in the study of angiogenesis and metastasis. Springer Science and Business Media, Dordrecth, pp 1-124
2. Koop S, Khokha R, Schmidt EE et al (1994) Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res 54:4791-4797
3. Koop S, Mac Donald IC, Luzzi K et al (1995) Fate of melanoma cells entering the microcirculation: over 80 % survive and extravasate. Cancer Res 55:2520-2523
4. Weber WT, Mausner R (1977) Migration patterns of avian embryonic bone marrow cells and their differentiation to functional T and B cells. In: Benedict AA (ed) Avian Immunology. Plenum Press, New York, pp 47-59
5. Maniotis AJ, Folberg R, Hess A et al (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155:739-752
6. van der Schaft DW, Seftor RE, Seftor EA et al (2004) Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells. J Natl Cancer Inst 96:1473-1477
7. Frank NY, Schatton T, Kim S et al (2011) VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth. Cancer Res 71:1474-1485
8. Vartanian A, Stepanova E, Grigorieva I, Solomko E, Baryshnikov A, Lichinitser M (2011) VEGFR1 and PKC alpha signaling control melanoma vasculogenic mimicry in a VEGFR2 kinase-independent manner. Melanoma Res 21:91-98
9. Wang JY, Sun T, Zhao XL et al (2008) Functional significance of VEGF-A in human ovarian carcinoma: role in vasculogenic mimicry. Cancer Biol Ther 7:758-766
10. Mangieri D, Nico B, Coluccia AML, Vacca A, Ponzoni M, Ribatti D (2009) An alternative in vivo system for testing angiogenic potential of human neuroblastoma cells. Cancer Lett 277:199-204
11. Westphal JR, Van't Hullenaar R, Peek R et al (2000) Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo. Int J Cancer 86:768-776
12. Ribatti D, Vacca A, Ria R et al (2003) Neovascularization, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur J Cancer 39:666-674
13. Ribatti D, Nico B, Floris C et al (2005) Microvascular density, vascular endothelial growth factor immunoreactivity in tumor cells, vessel diameter and intussusceptive microvascular growth in primary melanoma. Oncol Rep 14:81-84
14. Marcellini M, De Luca N, Riccioni T et al (2006) Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor. Am J Pathol 169:643-654
15. Cimpean AM, Ribatti D, Raica M (2008) The chick embryo chorioallantoic membrane as a model to study tumor metastasis. Angiogenesis 11:311-319
16. Shirakawa K, Wakasugi H, Heike Y et al (2002) Vasculogenic mimicry and pseudo-comedo formation in breast cancer. Int J Cancer 99:821-828
17. Sun T, Zhao N, Zhao XL et al (2010) Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry. Hepatology 51:545-556
18. Passalidou E, Trivella M, Singh N et al (2002) Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinoma. Br J Cancer 86:244-249
19. Sood AK, Seftor EA, Fletcher MS et al (2001) Molecular determinants of ovarian cancer plasticity. Am J Pathol 158:1279-1288
20. Sharma N, Seftor RE, Seftor EA et al (2002) Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry. Prostate 50:189-201
21. Favier J, Plouin PF, Corvol P, Gasc JM (2002) Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors. Am J Pathol 161:1235-1246
22. El Hallani S, Boisellier B, Peglion F et al (2010) A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry. Brain 133:973-982
23. Dome B, Hendrix MJC, Paku S, Tovari J, Timar J (2007) Alternative vascularization mechanisms in cancer pathology and therapeutic implications. Am J Pathol 170:1-15
24. Holash J, Maisonpierre PC, Compton D et al (1999) Vessel cooption, regression and growth in tumors mediated by angiopoietins and VEGF. Science 284:1994-1998
25. Ribatti D (2007) The discovery of endothelial precursor cells. An historical review. Leuk Res 31:439-444
26. Liu XM, Zhang QP, Mu YG et al (2011) Clinical significance of vasculogenic mimicry in human gliomas. J Neurooncol 105:173-179